Clinical Trial Update: Safety Follow-up Study of Inhaled Iloprost in Patients With Pulmonary Hypertension [Phase 3]

View source ↗

Summary

A Phase 3 safety follow-up study of inhaled iloprost in patients with pulmonary hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension

Drugs mentioned

• Iloprost (iloprost)

Snippet

Sponsor: Bayer | Conditions: Hypertension, Pulmonary | Phase 3 | Status: COMPLETED